These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 26140332)

  • 1. Impressive Response to Dose-Dense Chemotherapy in a Patient with NUT Midline Carcinoma.
    Maur M; Toss A; Dominici M; Frassoldati A; Corradini P; Maiorana A; Fontana A; Conte P
    Am J Case Rep; 2015 Jul; 16():424-9. PubMed ID: 26140332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NUT midline carcinoma mimicking a germ cell tumor: a case report.
    Harada Y; Koyama T; Takeuchi K; Shoji K; Hoshi K; Oyama Y
    BMC Cancer; 2016 Nov; 16(1):895. PubMed ID: 27855672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-fetoprotein elevation in NUT midline carcinoma: a case report.
    D'Ambrosio L; Palesandro E; Moretti M; Pelosi G; Fabbri A; Carnevale Schianca F; Aglietta M; Grignani G
    BMC Cancer; 2017 Apr; 17(1):266. PubMed ID: 28407756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NUT midline carcinoma: an aggressive intrathoracic neoplasm.
    Parikh SA; French CA; Costello BA; Marks RS; Dronca RS; Nerby CL; Roden AC; Peddareddigari VG; Hilton J; Shapiro GI; Molina JR
    J Thorac Oncol; 2013 Oct; 8(10):1335-8. PubMed ID: 24457244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I/II study of paclitaxel plus cisplatin as first-line chemotherapy for advanced non-small cell lung cancer: preliminary results.
    Belli L; LeChevalier T; Gottfried M; Adams D; Ruffie P; LeCesne A; Tete L; Pellae-Cosset B
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):29-33. PubMed ID: 8643967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of lung resection after chemotherapy due to lung metastases derived from esophageal cancer resection].
    Ohashi I; Miyata M; Tamura C; Inoue S; Takami K; Wakasa T
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2420-2. PubMed ID: 22202400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytologic findings of NUT midline carcinoma in the hilum of the lung.
    Policarpio-Nicolas ML; de Leon EM; Jagirdar J
    Diagn Cytopathol; 2015 Sep; 43(9):739-42. PubMed ID: 26138851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective trial of ifosfamide, paclitaxel, and cisplatin in patients with advanced non-transitional cell carcinoma of the urothelial tract.
    Galsky MD; Iasonos A; Mironov S; Scattergood J; Donat SM; Bochner BH; Herr HW; Russo P; Boyle MG; Bajorin DF
    Urology; 2007 Feb; 69(2):255-9. PubMed ID: 17320659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Staging and evaluation of neoadjuvant chemotherapy response with ¹⁸F-FDG PET/CT in NUT-midline carcinoma in a child: a case report and review of the literature.
    Ciftci E; Demirsoy U; Anik Y; Gorur G; Corapcioglu F; Demir H
    Rev Esp Med Nucl Imagen Mol; 2015; 34(1):53-5. PubMed ID: 25304847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dramatic response of penile cancer with inguinal lymph node metastases to neoadjuvant chemotherapy with paclitaxel, ifosfamide and cisplatin : a case report].
    Kubota Y; Nakano M; Nagai S; Matsuoka K; Arakawa H; Horie K; Deguchi T; Kato H
    Hinyokika Kiyo; 2015 Jan; 61(1):33-7. PubMed ID: 25656018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent metastatic anal cancer treated with modified paclitaxel, ifosfamide, and cisplatin and third-line mitomycin/cetuximab.
    Khawandanah M; Baxley A; Pant S
    J Oncol Pharm Pract; 2015 Jun; 21(3):232-7. PubMed ID: 24627343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First evidence of treatment efficacy in metastatic carcinoma of the parotid gland with BRD4/NUT translocation.
    Vulsteke C; Lurquin E; Debiec-Rychter M; Gheysens O; Nuyts S; Schoenaers J; Politis C; Mebis J; Hauben E; Clement PM
    J Chemother; 2016 Jun; 28(3):242-6. PubMed ID: 26027633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NUT midline lung cancer: a rare case report with literature review.
    Gupta R; Mumaw D; Antonios B; Anusim N; Dhulipalla SP; Stender M; Huben M; Jaiyesimi I
    AME Case Rep; 2022; 6():2. PubMed ID: 35128310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study.
    Choi N; Park SD; Lynch T; Wright C; Ancukiewicz M; Wain J; Donahue D; Mathisen D
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):111-22. PubMed ID: 15337546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II study of modified dose-dense paclitaxel and every 4-week carboplatin for the treatment of advanced-stage primary epithelial ovarian, fallopian tube, or peritoneal carcinoma.
    Abaid LN; Micha JP; Rettenmaier MA; Brown JV; Mendivil AA; Lopez KL; Goldstein BH
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):101-7. PubMed ID: 23660691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRD4-NUT carcinoma of the mediastinum in a pediatric patient: multidetector computed tomography imaging findings.
    Nelson BA; Lee EY; French CA; Bauer DE; Vargas SO
    J Thorac Imaging; 2010 Aug; 25(3):W93-6. PubMed ID: 20395873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Phase I/II trial of concurrent docetaxel and radiation after induction chemotherapy in patients with poor prognosis squamous cell carcinoma of the head and neck.
    Tishler RB; Norris CM; Colevas AD; Lamb CC; Karp D; Busse PM; Nixon A; Frankenthaler R; Lake-Willcutt B; Costello R; Case M; Posner MR
    Cancer; 2002 Oct; 95(7):1472-81. PubMed ID: 12237916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Midline carcinoma with t(15;19) and BRD4-NUT fusion oncogene in a 30-year-old female with response to docetaxel and radiotherapy.
    Engleson J; Soller M; Panagopoulos I; Dahlén A; Dictor M; Jerkeman M
    BMC Cancer; 2006 Mar; 6():69. PubMed ID: 16542442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of unresectable mediastinal carcinoma obtaining clinical complete response after sequential chemoradiotherapy].
    Yokouchi H; Murata K; Okada K; Ebisui C; Yanagisawa T; Murakami M; Nishigaki T; Owada Y; Kinuta M; Teshima T; Tamai M
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2194-6. PubMed ID: 22202327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase I/II study of paclitaxel plus cisplatin as first-line therapy for head and neck cancers: preliminary results.
    Hitt R; Hornedo J; Colomer R; Mendiola C; Brandariz A; Sevilla E; Alvarez-Vicent J; Cortés-Funes H
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):50-4. PubMed ID: 8643971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.